CANCER DE PROSTATA Tratamiento con radioterapia externa de intensidad modulada en
Development of monoclonal antibodies Workshop
Clinical Trial Protocol Review for Study Feasibility Analysis
Clinical Trial Process: Overview
Complete remissions with SGN-35 weekly dosing: a phase 1 dose-escalation study in relapsed/refractory HL or systemic ALCL patients Nancy L Bartlett, Andres.
Martin TG et al. Proc ASH 2013;Abstract 284.
SAR650984, a CD38 Monoclonal Antibody in Patients with Selected CD38+ Hematological Malignancies — Data from a Dose-Escalation Phase I Study Martin TG.
